Publication overview

Research center

Université de Limoges

Limoges, France

Université de Limoges

About the center

In France the Project MinE research is conducted at the University Hospital of Tours and the University Hospital of Limoges. The ALS centers of these hospitals are major referral centers for ALS patients in France. The dedicated teams provide multidisciplinary care for ALS patients and caregivers and are also engaged in clinical research. Research projects include studies in ALS genetics and clinical trials. The centers are committed to international collaborations to speed up the search for a cure of ALS and are therefore participating in Project MinE.

Philippe Couratier

Professor in Neurology

Université de Limoges

Philippe Couratier

Professor in Neurology

Professor Philippe Couratier is an expert in motor neuron diseases (MNDs). He is Neurologist in the University Hospital of Limoges since 1991. He is head of the Neurology Department and “Pôle Neurosciences Tête Cou et Os” of CHU Limoges, chairman of the Groupe Français d’Etude des Maladies du Motoneurone GFEMM and the Scientific Board for the “Association pour la Recherche sur la SLA (ARSla), coordinator of the ALS Centre CHU Limoges and member EURALS (Consortium for the European Research on Epidemiology of ALS), the French Network on FTD/ALS, and the French Neurological Society (SFN).

He is (co)investigator in several European Research Projects, such as Project MinE, TRICALS and SOPHIA, PULSE (PHRC; ‘Etude des facteurs prédictifs de l’évolutivité de la sclérose latérale amyotrophique’ Caractéristiques pronostiques et endophénotypiques. Mise en place d’une banque nationale de données’), and PREV-DEMALS (ANR; Predict to prevent frontotemporal lobar degeneration and amyotrophic lateral sclerosis), in therapeutic clinical trials (Cytokinetics, NogoA, Respistim). He is coordinator of Sub-Head: epidemiology of ALS UMR 1094 University of Limoges, BMAALS (ANR; First study in France searching a link between Amyotrophic Lateral Sclerosis and BMAA’s cyanotoxin) and NUTRALS (Impact d’une supplémentation alimentaire précoce par voie orale sur l’état fonctionnel des patients atteints de sclérose latérale amyotrophique).